In order to promote accountability and transparency, GDUFA II includes provisions so that industry and public stakeholders are able to observe the Agency’s productivity and performance with generic drug reviews under GDUFA II.
The links below provide data on GDUFA metrics and are updated periodically:
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
